These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34370838)

  • 1. Dietary phytoestrogen intake and lung cancer risk: an analysis of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.
    Wang Q; Ru M; Zhang Y; Kurbanova T; Boffetta P
    Carcinogenesis; 2021 Oct; 42(10):1250-1259. PubMed ID: 34370838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary phytoestrogen intake and ovarian cancer risk: a prospective study in the prostate, lung, colorectal and ovarian (PLCO) cohort.
    Song Y; Huang H; Jin M; Cheng B; Wang S; Yang X; Hu X
    Carcinogenesis; 2024 Jun; 45(6):378-386. PubMed ID: 38375679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Kunzmann AT; Coleman HG; Huang WY; Kitahara CM; Cantwell MM; Berndt SI
    Am J Clin Nutr; 2015 Oct; 102(4):881-90. PubMed ID: 26269366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fiber intake and the risk of bladder cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort.
    Luo J; Xu X
    Carcinogenesis; 2020 Jun; 41(4):478-482. PubMed ID: 31872237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials.
    O'Grady TJ; Kitahara CM; DiRienzo AG; Boscoe FP; Gates MA
    PLoS One; 2014; 9(9):e106880. PubMed ID: 25192282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary phytoestrogens and lung cancer risk.
    Schabath MB; Hernandez LM; Wu X; Pillow PC; Spitz MR
    JAMA; 2005 Sep; 294(12):1493-504. PubMed ID: 16189362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
    Gohagan JK; Prorok PC; Hayes RB; Kramer BS;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):251S-272S. PubMed ID: 11189683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.
    Kawakita D; Lee YA; Gren LH; Buys SS; La Vecchia C; Hashibe M
    Br J Cancer; 2018 Jan; 118(2):299-306. PubMed ID: 29161239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Stallings FL; Ford ME; Simpson NK; Fouad M; Jernigan JC; Trauth JM; Miller DS;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):379S-389S. PubMed ID: 11189689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Miller AB; Yurgalevitch S; Weissfeld JL;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):400S-406S. PubMed ID: 11189691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.
    Hayes RB; Reding D; Kopp W; Subar AF; Bhat N; Rothman N; Caporaso N; Ziegler RG; Johnson CC; Weissfeld JL; Hoover RN; Hartge P; Palace C; Gohagan JK;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):349S-355S. PubMed ID: 11189687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.
    Tammemagi CM; Pinsky PF; Caporaso NE; Kvale PA; Hocking WG; Church TR; Riley TL; Commins J; Oken MM; Berg CD; Prorok PC
    J Natl Cancer Inst; 2011 Jul; 103(13):1058-68. PubMed ID: 21606442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A different interpretation of the efficacy of lung cancer screening in the PLCO trial.
    Sagawa M; Nakayama T; Sobue T;
    Eur J Epidemiol; 2016 Feb; 31(2):211-2. PubMed ID: 26197850
    [No Abstract]   [Full Text] [Related]  

  • 14. Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Andriole GL
    Recent Results Cancer Res; 2014; 202():53-7. PubMed ID: 24531777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Hocking WG; Hu P; Oken MM; Winslow SD; Kvale PA; Prorok PC; Ragard LR; Commins J; Lynch DA; Andriole GL; Buys SS; Fouad MN; Fuhrman CR; Isaacs C; Yokochi LA; Riley TL; Pinsky PF; Gohagan JK; Berg CD;
    J Natl Cancer Inst; 2010 May; 102(10):722-31. PubMed ID: 20442215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Weissfeld JL; Fagerstrom RM; O'Brien B;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):390S-399S. PubMed ID: 11189690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary Advanced Glycation End-products (AGE) and Risk of Breast Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO).
    Omofuma OO; Turner DP; Peterson LL; Merchant AT; Zhang J; Steck SE
    Cancer Prev Res (Phila); 2020 Jul; 13(7):601-610. PubMed ID: 32169887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
    Lacey JV; Kreimer AR; Buys SS; Marcus PM; Chang SC; Leitzmann MF; Hoover RN; Prorok PC; Berg CD; Hartge P;
    BMC Cancer; 2009 Mar; 9():84. PubMed ID: 19292893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.
    Simpson NK; Johnson CC; Ogden SL; Gamito E; Trocky N; McGuire C; Martin J; Barrow S; Lamerato L; Flickinger LM; Broski KG; Engelhard D; Hilke C; Bonk J; Gahagan B; Gren LH; Childs J; Lappe K; Fouad M; Thompson J; Sullivan D;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):356S-378S. PubMed ID: 11189688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary intake of isoflavones and coumestrol and the risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Reger MK; Zollinger TW; Liu Z; Jones JF; Zhang J
    Int J Cancer; 2018 Feb; 142(4):719-728. PubMed ID: 29114854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.